| MolName | 3-[[3-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]indol-1-yl]methyl]benzoic acid |
| MolecularFormula | C26H19N3O4 |
| Smiles | OC(c1cccc(Cn2c(cccc3)c3c(/C=C(/C(NN3c4ccccc4)=O)\C3=O)c2)c1)=O |
| InChI | InChI=1S/C26H19N3O4/c30-24-22(25(31)29(27-24)20-9-2-1-3-10-20)14-19-16-28(23-12-5-4-11-21(19)23)15-17-7-6-8-18(13-17)26(32)33/h1-14,16H,15H2,(H,27,30)(H,32,33) |
| InChIK | LWHKSYHVXUYEKK-UHFFFAOYSA-N |
| TotalMolweight | 437.454 |
| Molweight | 437.454 |
| MonoisotopicMass | 437.137557 |
| CLogP | 2.3584 |
| CLogS | -3.881 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 322.91 |
| Relative PSA | 0.22948 |
| PolarSurfaceArea | 91.64 |
| Druglikeness | 5.1387 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.51515 |
| Fragments | 1 |
| Non HAtoms | 33 |
| NonCHAtoms | 7 |
| Electronegative Atoms | 7 |
| Rotatable Bond | 5 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 21 |
| Sp3Atoms | 2 |
| Symmetricatoms | 2 |
| Aromatic Nitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 3-[[3-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]indol-1-yl]methyl]benzoic acid | 2 - 3-[[3-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]indol-1-yl]methyl]benzoic acid